Circ MedTech
Non-Surgical Male Circumcision Device
Company Overview
Snapshot
Founded in January 2010 by Tzameret Fuerst, Circ MedTech operates with 1–10 employees. The company developed the PrePex device, which gained significant recognition when the WHO expanded its use to adolescents in May 2016.
Business overview
Circ MedTech develops medical devices within the Health Tech & Life Sciences sector, focusing on non-surgical solutions. Its core product, PrePex, is designed to facilitate safe, simple, scalable, and cost-effective non-surgical adult male circumcision programs. The company serves public health initiatives and healthcare providers in markets such as India, the United States, Africa, and Indonesia, aiming to contribute to comprehensive HIV prevention efforts.
Strategic signal
In November 2017, the non-surgical circumcision device PrePex was highlighted for its role in curbing HIV transmission in Rwanda. This signals the device's validated effectiveness and its potential for significant public health impact, demonstrating strong clinical and societal relevance for investors and innovation teams focused on global health solutions.
Log in to access full profile ›Company Intelligence Q&A
- What is Circ MedTech's primary product?
- Circ MedTech's primary product is PrePex, a non-surgical device designed for adult male circumcision programs aimed at HIV prevention.
- When was Circ MedTech founded?
- Circ MedTech was founded in January 2010.
- What was a key development for the PrePex device in 2016?
- In May 2016, the World Health Organization (WHO) expanded the use of the PrePex device to adolescents.
- How has PrePex been recognized for its impact?
- In November 2015, the PrePex non-invasive circumcision device won a top tech award. In November 2017, it was recognized for curbing HIV transmission in Rwanda.
- Who is a co-founder of Circ MedTech?
- Tzameret Fuerst is a co-founder of Circ MedTech.